IVP Ltd Valuation Shifts to Very Attractive Amidst Sector Peers

Valuation Metrics Highlight a Compelling Opportunity

As of early July 2026, IVP Ltd trades at a P/E ratio of 8.62, a figure that stands out starkly against the backdrop of its peer group. For context, competitors such as Sanstar and Stallion India command P/E ratios of 70.08 and 48.26 respectively, while others like Titan Biotech and I G Petrochems trade at even more elevated multiples of 51.4 and 618.74. This disparity emphasises IVP’s current undervaluation relative to the sector.

Complementing the P/E ratio, IVP’s price-to-book value of 1.14 further supports the thesis of undervaluation. This metric is considerably lower than many peers, with Indo Borax & Chemicals at 28.16 and Gulshan Polyols at 28.03, indicating that IVP’s stock price is trading close to its net asset value, a factor often favoured by value-oriented investors.

Enterprise value multiples also reinforce this narrative. IVP’s EV to EBITDA ratio stands at 7.60, markedly below the sector heavyweights such as Sanstar (60.37) and Stallion India (29.64). Such low multiples suggest that the market is pricing IVP’s earnings and cash flow at a discount, potentially reflecting either market scepticism or an opportunity for value investors to capitalise on.

Comparative Analysis with Peers and Historical Context

IVP’s valuation improvement is particularly noteworthy when viewed against its historical performance and the broader market. The company’s PEG ratio, a measure that adjusts the P/E ratio for earnings growth, is an exceptionally low 0.13, indicating that the stock is undervalued even after accounting for growth prospects. This contrasts sharply with peers like Titan Biotech, whose PEG ratio of 1.33 suggests a premium valuation relative to growth.

From a returns perspective, IVP has delivered mixed results over various time horizons. Year-to-date, the stock has gained 9.25%, outperforming the Sensex which is down 9.74%. However, over the one-year period, IVP has declined by 20.30%, underperforming the Sensex’s 8.09% loss. Longer-term returns over five and ten years show gains of 24.35% and 53.13% respectively, though these lag the Sensex’s 47.03% and 183.38% returns. This performance history may partly explain the cautious market valuation, despite recent improvements.

Financial Health and Profitability Metrics

IVP’s return on capital employed (ROCE) and return on equity (ROE) stand at 7.91% and 13.21% respectively, reflecting moderate profitability levels. While these figures are not industry-leading, they provide a stable foundation for the company’s operations. Dividend yield remains modest at 0.63%, which may limit appeal for income-focused investors but aligns with the company’s growth and reinvestment strategy.

Enterprise value to capital employed (EV/CE) at 1.08 and EV to sales at 0.44 further indicate that IVP is trading at a discount to its asset base and revenue generation capacity, reinforcing the very attractive valuation grade assigned recently.

Market Capitalisation and Recent Price Movements

IVP Ltd is classified as a micro-cap stock, with a current market price of ₹158.80, marginally up 0.28% from the previous close of ₹158.35. The stock’s 52-week trading range spans from ₹111.20 to ₹207.05, indicating a significant volatility band. Today’s intraday high and low were ₹161.20 and ₹158.80 respectively, suggesting a relatively stable trading session.

Despite the micro-cap status, IVP’s Mojo Score has improved to 72.0, upgrading its Mojo Grade from Hold to Buy as of 12 June 2026. This upgrade reflects the enhanced valuation attractiveness and improved market sentiment towards the stock.

Investment Implications and Outlook

The marked improvement in IVP’s valuation parameters, especially the P/E and P/BV ratios, positions the stock as a compelling candidate for value investors seeking exposure in the Commodity Chemicals sector. The very attractive valuation grade, combined with a low PEG ratio, suggests that the market may be underestimating the company’s growth potential and earnings stability.

However, investors should weigh the company’s moderate profitability metrics and historical return volatility against the valuation appeal. The stock’s underperformance relative to the Sensex over the medium term warrants cautious optimism, with a focus on monitoring operational improvements and sector dynamics.

Overall, IVP Ltd’s current price levels offer a rare entry point in a sector where many peers trade at steep premiums. The upgrade to a Buy rating by MarketsMOJO underscores this opportunity, signalling that the stock’s risk-reward profile has improved materially.

Conclusion

IVP Ltd’s transition from an attractive to a very attractive valuation grade is a significant development for investors analysing commodity chemical stocks. Its low P/E of 8.62 and P/BV of 1.14 stand in sharp contrast to the expensive multiples seen across its peer group, highlighting a potential undervaluation. While the company’s financial performance and market cap remain modest, the improved valuation metrics and positive Mojo Grade upgrade provide a strong case for inclusion in a value-focused portfolio.

Investors should continue to monitor IVP’s earnings trajectory, sector trends, and broader market conditions to capitalise on this valuation shift effectively.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →